Morgan Stanley just upgraded HPE to Overweight after a stock run that most investors missed entirely, and the valuation argument for buying near a 52-week high is more complicated than it looks.
She wiped out $28,000 in credit card debt through a negotiated settlement, but the relief came with two delayed consequences she never saw coming, one from the IRS and another that would follow her into Medicare two years later.
The reaction to Fermi's Q2 earnings is intensifying: a 9% slide to $6.92 wipes out the resistance test traders were watching hours ago. Next level to hold is the $6.90 area.
Down 4.4% to $340 in the session right after Coherent's Q4 2026 earnings beat, so buyers are treating good numbers as a chance to take profits in an AI-optics leader. Keep an eye on whether $340 holds.
Intel has staged one of the most dramatic stock revivals in recent memory, but two unresolved catalysts will either confirm the turnaround as real or expose this year’s triple-digit rally as a trade that ran far ahead of the fundamentals.
Sponsored
Most Americans suspect they're behind on retirement and never find out. Advisor.com's free matching tool pairs you in about three minutes with a vetted fiduciary advisor who can help you with investing, taxes, retirement, estate planning, and more. No minimums. No sales call. Find out where you stand.
The selling is picking up speed: a 13.82% drop to $225.85 in the session after Cerebras' Q2 2026 earnings miss. Anyone who bought the first dip near $233 is already underwater, so keep an eye on where buyers step back in.
Down 9.65% to $111.92, and this is a mega-cap that rarely moves this hard in a single session. The selling follows last night's Q4 earnings beat, so the market is pricing something other than the headline numbers.
An 11% slide to $232.98 puts the first real dent in Cerebras since its Q2 2026 earnings report missed expectations.
Down 6.05% to $7.14 in the first session after Fermi's Q2 2026 results hit EDGAR, and the slide takes the stock back below the $7.74 resistance traders were watching. Next test is whether it holds here or slips further.
Arm just posted its third straight year of 20-plus percent revenue growth with the AI era’s dominant compute platform, yet the stock sits 33% below its recent peak and Wall Street’s upside calls look surprisingly timid given what the AGI CPU pipeline could actually deliver.
Buyers stepped in at the open with the S&P 500 adding 36.98 points, betting the Fed stays on hold after another cooler inflation reading. Wholesale inflation data is the next test for this bid.
*$149 for two years (or $1.43 per week) is an introductory promotion for new members only. 62% discount based on the current list price of Stock Advisor of $199/year. Membership will renew at the then-current list price at the end of the membership term. Stock Advisor returns are 930% as compared to the S&P 500 returns of 185% as of April 7, 2026.
The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.
